2009-11-10 00:03:03 -
Javelin Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/javelin-phar ..
Javelin Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Javelin Pharmaceuticals, Inc. (Javelin) is a specialty pharmaceutical company focused on the development of new drugs and improved formulations of existing drugs with its innovative proprietary technologies that target current unmet and underserved medical need in the pain management market. It has product candidates for acute moderate-to-severe pain, post-operative
pain, orthopedic injury pain, procedural pain, burn pain and trauma. It has three late stage product candidates in development, namely, Dyloject, Rylomine, and Ereska. The company is headquartered in Cambridge, Maryland, the United States
The Javelin Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
